We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.5B
AUM Growth
+$378M
Cap. Flow
+$252M
Cap. Flow %
1.74%
Top 10 Hldgs %
26.25%
Holding
735
New
61
Increased
261
Reduced
285
Closed
31

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$73.6M
2
GILD icon
Gilead Sciences
GILD
+$57M
3
MSFT icon
Microsoft
MSFT
+$44.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.6M
5
NU icon
Nu Holdings
NU
+$38M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$112M
2
RY icon
Royal Bank of Canada
RY
+$44.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.1M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$38.9M
5
MRK icon
Merck
MRK
+$31.7M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Healthcare 28.88%
3 Consumer Discretionary 8.63%
4 Financials 8.52%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.89T
$908M 6.27%
2,414,863
+123,989
+5% +$44.1M
AAPL icon
2
Apple
AAPL
$4.77T
$671M 4.63%
3,483,189
+53,547
+2% +$9.89M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.25T
$453M 3.13%
3,242,872
+287,515
+10% +$38.6M
MRK icon
4
Merck
MRK
$317B
$330M 2.28%
3,030,289
-305,310
-9% -$31.7M
NVDA icon
5
NVIDIA
NVDA
$5.17T
$296M 2.04%
5,971,100
+170,140
+3% +$7.88M
TMO icon
6
Thermo Fisher Scientific
TMO
$194B
$263M 1.81%
495,267
+37,855
+8% +$18.3M
UNH icon
7
UnitedHealth
UNH
$394B
$232M 1.6%
440,548
+3,851
+0.9% +$2.05M
LLY icon
8
Eli Lilly
LLY
$1.04T
$220M 1.52%
377,512
+61,449
+19% +$35.9M
AMGN icon
9
Amgen
AMGN
$199B
$219M 1.51%
759,421
-102,316
-12% -$27.9M
REGN icon
10
Regeneron Pharmaceuticals
REGN
$69.7B
$212M 1.46%
241,618
-48,692
-17% -$40.1M
V icon
11
Visa
V
$676B
$200M 1.38%
769,963
+298,684
+63% +$73.6M
GILD icon
12
Gilead Sciences
GILD
$163B
$181M 1.25%
2,240,237
+732,381
+49% +$57M
AMZN icon
13
Amazon
AMZN
$2.62T
$165M 1.14%
1,083,373
+916
+0.1% +$128K
MA icon
14
Mastercard
MA
$473B
$156M 1.08%
365,295
+55,807
+18% +$22.4M
PG icon
15
Procter & Gamble
PG
$350B
$152M 1.05%
1,035,950
-104,919
-9% -$15.5M
DHR icon
16
Danaher
DHR
$126B
$145M 1%
628,314
-65,849
-9% -$14M
ADBE icon
17
Adobe
ADBE
$88B
$144M 0.99%
241,450
-7,070
-3% -$4.08M
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$120B
$139M 0.96%
342,086
-42,245
-11% -$15.6M
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.23T
$136M 0.94%
968,227
+3,054
+0.3% +$414K
AMD icon
20
Advanced Micro Devices
AMD
$906B
$136M 0.94%
920,563
+208,558
+29% +$24.6M
NOW icon
21
ServiceNow
NOW
$99.9B
$132M 0.91%
934,940
-36,505
-4% -$4.6M
WM icon
22
Waste Management
WM
$94.2B
$118M 0.81%
656,785
+126,682
+24% +$21.2M
PANW icon
23
Palo Alto Networks
PANW
$273B
$117M 0.81%
796,838
-89,510
-10% -$12M
CSCO icon
24
Cisco
CSCO
$445B
$111M 0.77%
2,194,612
+444,429
+25% +$22.7M
CRM icon
25
Salesforce
CRM
$135B
$110M 0.76%
417,320
+26,954
+7% +$6.1M
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2023 Portfolio in Review

As of Q4 2023, Candriam SCA held 735 positions worth $14.5B, up 2.7% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Candriam SCA's Q4 2023 filing shows 61 new, 261 increased, 285 reduced and 31 closed positions. Its largest new stake was Nu Holdings: 4,696,438 shares worth $39.1M. The largest sale was Seagen Inc. Common Stock, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Candriam SCA's largest Q4 2023 buy was Nu Holdings: 4,696,438 shares worth $39.1M.
  • Candriam SCA added most to Visa in Q4 2023, an estimated $73.6M increase.
  • Candriam SCA's biggest Q4 2023 reduction was Royal Bank of Canada, cutting an estimated $44.3M.
  • Candriam SCA fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $112M.
  • Candriam SCA's ten largest holdings make up 26% of its $14.5B portfolio in Q4 2023.
  • Candriam SCA opened 61 new positions and closed 31 in Q4 2023.
  • Candriam SCA's portfolio value rose 2.7% quarter-over-quarter to $14.5B.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.